Sanofi
SNY
456 hedge funds and large institutions have $11.6B invested in Sanofi in 2013 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 161 increasing their positions, 156 reducing their positions, and 42 closing their positions.
19% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 42
3% more repeat investments, than reductions
Existing positions increased: 161 | Existing positions reduced: 156
2% more call options, than puts
Call options by funds: $39.2M | Put options by funds: $38.5M
1% more funds holding
Funds holding: 453 → 456 (+3)
0.07% more ownership
Funds ownership: 17.17% → 17.25% (+0.07%)
0% less capital invested
Capital invested by funds: $11.6B → $11.6B (-$57.1M)
11% less funds holding in top 10
Funds holding in top 10: 18 → 16 (-2)
Top Buyers
Top Sellers
SNY Hedge Fund Activity: Q3 2013 in Review
456 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q3 2013, worth a combined $11.6B — down 0.49% from $11.6B a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new SNY positions and 42 closed out — a net gain of 8 holders — while 161 added to existing stakes and 156 trimmed.
The largest buyer was Barrow, Hanley, Mewhinney & Strauss, adding an estimated $828M. The largest seller was Winslow Capital Management, exiting entirely with an estimated $477M sold.
- 456 institutional investors held Sanofi (SNY) as of Q3 2013, up from 453 in Q2 2013.
- Funds reported $11.6B of Sanofi stock for Q3 2013, down 0.49% quarter-over-quarter.
- 50 funds opened new Sanofi positions in Q3 2013 and 42 closed out, a net change of +8 holders.
- The largest Sanofi buyer in Q3 2013 was Barrow, Hanley, Mewhinney & Strauss, an estimated $828M added.
- The largest Sanofi seller in Q3 2013 was Winslow Capital Management, an estimated $477M sold.
Based on aggregated 13F filings for Q3 2013.